Stealth BioTherapeutics Inc. - Company Profile
Powered by 
All the data and insights you need on Stealth BioTherapeutics Inc. in one report.
$295
- Save hours of research time and resources with
our up-to-date Stealth BioTherapeutics Inc. Strategy Report
- Understand Stealth BioTherapeutics Inc. position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Stealth BioTherapeutics Inc. patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20240108740A1 | Application | Therapeutic compositions including spn10 and uses thereof | A61K45/06; A61K47/645; C07K7/06 | April 04, 2024 |
| US11944662B2 | Grant | Methods and compositions for preventing or treating ophthalmic conditions | A61K38/06; A61K38/07; A61K45/06; A61P27/02; A61P27/12; C07K5/0817; C07K5/1016 | April 02, 2024 |
| US20240100119A1 | Application | Methods and compositions for the prevention and treatment of friedreich's ataxia | A61K2300/00; A61K31/122; A61K31/401; A61K31/4412; A61K31/7048; A61K38/07; A61K38/28; A61K45/06; A61K9/5052; A61P21/00; A61P25/28; A61P43/00; A61Q19/08; C07K5/10; C07K5/1019; G01N2800/2835; G01N33/68 | March 28, 2024 |
| EP4302829A3 | Search Report | Peptid zur verwendung bei der vorbeugung oder behandlung von makula degenerationugenleiden | A61K38/06; A61K38/07; A61K45/06; A61P27/02; A61P27/12; C07K5/0817; C07K5/1016 | March 27, 2024 |
| US20240092832A1 | Application | Deuterated tetrapeptides that target mitochondria | A61K38/00; A61P13/12; C07K5/1016 | March 21, 2024 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer